Companies: 10,795·Total market cap: $144.5T
Evome Medical Technologies Inc.

Evome Medical Technologies Inc.

LNDZFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$5981
P/E Ratio
52W High$0.006
52W Low$0.0001

Evome Medical Technologies Inc. (LNDZF) Revenue

Annual & quarterly revenue history · segment & region breakdown

LNDZF · revenue · updated Jun 9, 2026

Core revenue metrics

Evome Medical Technologies Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
195 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Evome Medical Technologies Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
LNDZF revenue by year · LNDZF revenue history · LNDZF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Evome Medical Technologies Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Evome Medical Technologies Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Evome Medical Technologies Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

LNDZF revenue · 4 questions

LNDZF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

LNDZF revenueLNDZF annual revenuewhat is LNDZF revenueLNDZF TTM revenue

Source: FMP · Evome Medical Technologies Inc. SEC filings · GAAP · Evome Medical Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026